CaroGen Corporation's Grant

CaroGen Corporation raised a round of funding on August 05, 2014. Investors include Connecticut Innovations.

CaroGen provides a platform technology for generating vaccines, which is based on replication-proficient, virus-like vesicles (rVLVs) allowing target antigens to accumulate in high levels in cells, th…

Articles about CaroGen Corporation's Grant: